Many people can have polyps and, like Andy, have no symptoms. A polyp can take as many as 10 to 15 years to develop into ...

Colon cancer is the second leading cause of cancer-related deaths globally. This cancer often develops silently, with symptoms emerging only in later stages. Early detection can significantly ...

As scientists question the rise in early colon cancer cases, a new study is offering some potential answers. Colored scanning electron micrograph (SEM) of a macrophage white blood cell (center ...

Colorectal cancer may be treated with a laparoscopic abdominoperineal resection, an operation in which the anus, rectum, and sigmoid colon are removed and a colostomy performed. Learn more from WebMD.

Bryce Ramsey was crowned Mrs. Mississippi Plus America in 2024. She wears the color blue because it’s associated with colon cancer awareness. Courtesy Bryce Ramsey Friends and family were ...

Colonoscopy and sigmoidoscopy are both procedures that can help your doctor understand what’s happening inside your colon. A colonoscopy offers a full view of the large intestine and is the best ...

New Jersey mom of six Elaine Griffin recalls the four main symptoms that led to her being diagnosed with Stage 2b colon cancer last year. Colorectal cancer is on the rise among people under 50 ...

Some people have a sigmoid colon that’s a bit longer than usual, which is a normal variation in human anatomy, she adds. “I was always told I had a long colon,” Grenham recalls.

The descending colon sits on the left side of the large intestine next to the splenic fixture (the sharp bend in the colon) and ends by joining the sigmoid colon. It falls behind the peritoneum—the ...

Similar measurements were made of the various layers of the sigmoid colon in 20 additional specimens that had been resected for chronic ulcerative colitis but in which there were no strictures ...

Background: Signet-ring cell carcinoma (SRCC) of the rectum and sigmoid colon is a rare and highly malignant challenge in clinical practice. Although high PD-1+CD8+ tumor-infiltrating lymphocyte (TIL) ...